Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson's Disease and "OFF" Episodes: A Pooled Analysis

被引：0
|
作者：
Ondo, W.
Ellenbogen, A.
Isaacson, S.
Espay, A.
Singer, C.
Bhargava, P.
Worden, M.
Blum, D.
Navia, B.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1007
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and tolerability of apomorphine sublingual film during titration in patients with Parkinson's disease and "off" episodes: a pooled analysis
    Ondo, W.
    Ellenbogen, A.
    Isaacson, S.
    Espay, A.
    Singer, C.
    Bhargava, P.
    Worden, M.
    Blum, D.
    Navia, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 236 - 236
  • [2] Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Chaudhuri, R.
    Kassube, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    MOVEMENT DISORDERS, 2022, 37 : S348 - S348
  • [3] Efficacy, Safety, and Tolerability of Supratherapeutic Doses of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Wilks, K.
    Peckham, E.
    De Pandis, M.
    Sciarappa, K.
    Kleiman, R.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34
  • [4] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [5] Efficacy of apomorphine sublingual film versus subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's Disease
    Stocchi, F.
    Rascol, O.
    Poewe, W.
    Chaudhuri, R.
    Kassubek, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    MOVEMENT DISORDERS, 2022, 37 : S356 - S356
  • [6] APOMORPHINE SUBLINGUAL FILM FOR "OFF" EPISODES IN PARKINSON'S DISEASE: ANALYSIS OF BASELINE FACTORS
    Nicholas, A. P.
    Singer, C.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 43 - 43
  • [7] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Analysis of Baseline Factors
    Nicholas, A.
    Singer, C.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S188 - S189
  • [8] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Pappert, Eric
    Dzyngel, Bruce
    Bllbault, Thierry
    Argo, Albert
    NEUROLOGY, 2016, 86
  • [9] Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease
    Isaacson, S.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 250 - 250
  • [10] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S47 - S47
12345